BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
LYNBROOK, N.Y., Oct. 20 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Pink Sheets: BSTC) today announced that Mr. Thomas Wegman, President, will present an overview of the company and it's product pipeline at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LL...AutoImmune Inc. Reports 2009 Second Quarter Financial Results
...ur licensee, Bronson Laboratories, LLC remains encouraging." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46R "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights pertaining t...AutoImmune Inc. Reports 2009 First Quarter Financial Results
...ur licensee, Bronson Laboratories, LLC remains encouraging." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46R "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medic...AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results
...ugh our licensee, Bronson Laboratories, LLC is encouraging." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46R "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medic...AutoImmune Inc. Reports 2008 Third Quarter Financial Results
...hird quarter were unchanged from the same period prior year." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46 "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical C...AutoImmune Inc. Reports 2008 Second Quarter Financial Results
...Colloral LLC met our expectations during the second quarter." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46 "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical C...AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
...eting through The Shopping Channel in Canada is encouraging." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with fin 46 "Consolidation of Variable Interest Entities." AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical C...